InflaRx (IFRX) Receivables - Other (2025)
InflaRx's (IFRX) quarterly Receivables - Other came in at $2.9 million in Q4 2025.
InflaRx (IFRX) Receivables - Other (2025) Analysis & Trends
InflaRx has disclosed Receivables - Other across 1 years of filings, most recently posting $2.9 million for Q4 2025.
- Receivables - Other for Q4 2025 came in at $2.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 million (changed N/A YoY), and the FY2025 annual result was $2.9 million, changed N/A from the prior year.
- Receivables - Other came in at $2.9 million for Q4 2025 at InflaRx.
- In the past five years, Receivables - Other ranged from a high of $2.9 million in Q4 2025 to a low of $2.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.91 Mn |
| Dec 31, 2025 | 2.91 Mn |